AGREEMENT AND PLAN OF MERGERMerger Agreement • April 27th, 2005 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances) • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of April 21, 2005, among Transkaryotic Therapies, Inc., a Delaware corporation (the “Company”), Shire Pharmaceuticals Group plc, a public limited company incorporated under the laws of England and Wales (“Parent”), and Sparta Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Subsidiary”).
TRANSKARYOTIC THERAPIES, INC. 700 Main Street Cambridge, MA 02139 Phone: (617) 349-0200 April 21, 2005Resignation Agreement • April 27th, 2005 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances)
This letter is to confirm our agreement that, effective as of the date of this letter, you hereby resign as an officer and an employee of Transkaryotic Therapies, Inc.(the “Company”) and as a member of the Board of Directors of the Company.
RECITALSExclusive License Agreement • April 27th, 2005 • Transkaryotic Therapies Inc • Biological products, (no disgnostic substances) • Delaware
